🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cancer Cachexia

A Study of JMT203 in Patients With Cancer Cachexia NCT06868849Phase 1, Phase 21 site📍 Zhejiang Shanghai JMT-Bio Inc. · Tests: JMT203 Injection, JMT203 Injection A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cachexia NCT07243379Phase 41 site📍 Zhengzhou Changchun GeneScience Pharmaceutical Co., Ltd. · Tests: Nanocrystalline Megestrol Acetate Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer NCT07408505NA1 site📍 Jinan Shandong Cancer Hospital and Institute · Tests: Nano-crystalline megestrol acetate, First-line Chemotherapy Neurobehavioural and Cognitive Changes in Cancer Cachexia (CANCOG) NCT06112964n/a1 site📍 Cambridge University of Cambridge · Tests: MRI/ Functional MRI, Self-reported questionnaires, Computer based tasks Visugromab in Cachexia International Trial NCT07112196Phase 2, Phase 374 sites📍 Norwich📍 Clermont📍 Orange City CatalYm GmbH · Tests: Visugromab (CTL-002), Placebo, Visugromab (CTL-002), Visugromab (CTL-002) Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients NCT07130981n/a1 site📍 Ankara Hacettepe University MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatment NCT05723718n/a1 site📍 Lublin Medical University of Lublin · Tests: Observational Survey Influence of Sarcopenia on the Course of the Diseases NCT06829290n/a1 site📍 Mainz Universitatsmedizin Mainz - 1. Medizinische Klinik · Tests: Ultrasound A Phase I Clinical Study to Evaluate the Efficacy and Safety of GB18 Injection in Patients With Tumor Cachexia NCT07519564Phase 12 sites📍 Beijing📍 Beijing Kexing Biopharm Co., Ltd. · Tests: GB18 A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue NCT06989437Phase 2, Phase 3230 sites📍 Birmingham📍 Birmingham📍 Phoenix Pfizer · Tests: ponsegromab, placebo Cancer-associated Muscle Mass - Molecular Factors and Exercise Mechanisms NCT05307367NA1 site📍 Copenhagen University of Copenhagen · Tests: Exercise training To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants NCT07237464Phase 11 site📍 Beijing Shenzhen Kexing Pharmaceutical Co., Ltd. · Tests: GB18 injection, Placebo A Clinico-biological Database in Cachexia in Patients With Colon Cancer NCT05257135NA1 site📍 Montpellier Institut du Cancer de Montpellier - Val d'Aurelle · Tests: Biological collection Inflammation, Cachexia and Therapeutic Response in Lung Cancer Treated With Immune Checkpoint Inhibitors: Exploratory Observational Study NCT07004868n/a1 site📍 Tours University Hospital, Tours The First in Human Study of QLS2319 in Healthy Subjects and Cancer Cachexia NCT07735104Phase 1, Phase 22 sites📍 Hefei📍 Guangzhou Qilu Pharmaceutical Co., Ltd. · Tests: QLS2319, Placebo A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia NCT05865535Phase 112 sites📍 Beverly Hills📍 Lakewood📍 Newport Beach AVEO Pharmaceuticals, Inc. · Tests: AV-380 An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia. NCT07033026Phase 228 sites📍 Los Angeles📍 Los Angeles📍 Santa Rosa NGM Biopharmaceuticals, Inc · Tests: NGM120 Q4W, NGM120 Q8W, Placebo given Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder NCT07072728Phase 23 sites📍 Abbotsford📍 Northcote📍 Leederville Psyence Australia Pty Ltd · Tests: Psilocybin therapy REVOLUTION Surgery (REVOLUTION Surgery) NCT05642819n/a1 site📍 Edinburgh University of Edinburgh A First-in-Human Study of FID-022 in Solid Tumor Patients NCT07249775n/a1 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Baseline Lifestyle and Symptom Assessment, Extended Lifestyle Monitoring, Feasibility Survey Influence of Protein Intake on Muscle Mass and Health-related Quality of Life During and After Radiotherapy NCT06480266n/a1 site📍 Berlin Charite University, Berlin, Germany Structural Characteristics of Trunk and Limb Muscles in Cachectic Colorectal Cancer Patients NCT06780423n/a2 sites📍 Diepenbeek📍 Hasselt Hasselt University · Tests: Minimal invasive fine needle muscle biopsies A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of SXRN Injection in Patients With Cancer Cachexia NCT07231120Phase 11 site📍 Beijing Jiangsu Nutai Biologics Co., Ltd · Tests: SXRN Injection Study on the Pathogenesis and Reversal Strategies of Cancer Cachexia Based on Multi-Omics NCT07519837NA1 site📍 Shenyang China Medical University, China · Tests: Validation of intervention efficacy through enhanced intervention in nutritionally high-risk patients, Standard nutriti… Patient Recorded Indexing Measurements NCT05899205n/a2 sites📍 Maastricht📍 Sittard Academisch Ziekenhuis Maastricht A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors NCT06736275EARLY Phase 11 site📍 Beijing Jiangsu Nutai Biologics Co., Ltd · Tests: SXRN, Placebo Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer NCT05705492Phase 21 site📍 Portland OHSU Knight Cancer Institute · Tests: Olanzapine, Placebo Administration, Questionnaire Administration Routine Evaluation of People Living With Cancer NCT04406662n/a1 site📍 Edinburgh University of Edinburgh A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or Cachexia NCT06898255Phase 11 site📍 Guangzhou Genfleet Therapeutics (Shanghai) Inc. · Tests: GFS202A injection Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative Chemotherapy NCT07633236Phase 31 site📍 Moscow Blokhin's Russian Cancer Research Center · Tests: OLANZapine 2.5 MG
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy